MedTrace Logo

Resilience Enhancement Online Training for Nurses (REsOluTioN) Trial

NCT05074563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-05-26

No results posted yet for this study

Summary

The purpose of the study is to pilot a new training which aims to foster resilience to some of the clinical and workload pressures that nurses encounter on a daily basis.

Conditions

  • Resilience

Interventions

OTHER

REsOluTioN (Resilience Enhancement Online Training for Nurses)

The online REsOluTioN training involves virtual or face-to-face mentorship sessions and facilitated online interactive group sessions on four topics (Building hardiness and maintaining a positive outlook, Intellectual flexibility and Emotional Intelligence; Achieving life balance and enabling spirituality and Reflective and critical thinking). The training will be of four-week duration. Over the four-week period, the training will comprise 4x120 minute facilitated online group sessions; 4x30 minute independent learning activities; and eight 3:1 online mentoring sessions delivered between 30 and 60 minutes at flexible timings.

OTHER

Control

Nurses randomised to the control group will only be invited to take part in the pre- and post- intervention surveys, but will not use the online training. However, after completing the survey, nurses will be given the opportunity to complete the pre-work and access the facilitated sessions of the training so that they can receive their CPD certificate.

Sponsors & Collaborators

  • Oxford Brookes University

    lead OTHER

Principal Investigators

  • Cathy Henshall, PhD · Oxford Brookes University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-02-14
Completion
2022-04-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05074563 on ClinicalTrials.gov